Antitumor activity of epigenetic immunomodulation combined with CTLA-4 blockade in syngeneic mouse models

The multifaceted immunomodulatory activity of DNA hypomethylating agents improves immunogenicity and immune recognition of neoplastic cells; thus, we predicted they could be utilized to design new immunotherapeutic combinations in cancer. Testing this hypothesis, the antitumor efficacy of the DNA hy...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Oncoimmunology
Päätekijät: Covre, A, Coral, S, Nicolay, H, Parisi, G, Fazio, C, Colizzi, F, Fratta, E, Di Giacomo, A M, Sigalotti, L, Natali, P G, Maio, M
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Taylor & Francis 2015
Aiheet:
Original Research
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC4570131/
https://ncbi.nlm.nih.gov/pubmed/26405573
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/2162402X.2015.1019978
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia